Effect of ginkgo diterpene lactone meglumine on the quality of life in patients with acute ischemic stroke

go back to reference van der Ende NAM, den Hartog SJ, Broderick JP, Khatri P, Visser-Meily JMA, van Leeuwen N, Lingsma HF, Roozenbeek B, Dippel DWJ. Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke. Neurology. 2023;100:e1321–8.PubMedPubMedCentral van der Ende NAM, den Hartog SJ, Broderick JP, Khatri P, Visser-Meily JMA, van Leeuwen N, Lingsma HF, Roozenbeek B, Dippel DWJ. Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke. Neurology. 2023;100:e1321–8.PubMedPubMedCentral

go back to reference Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835–40.CrossRefPubMed Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835–40.CrossRefPubMed

go back to reference Muus I, Ringsberg KC. Stroke Specific Quality of Life Scale: Danish adaptation and a pilot study for testing psychometric properties. Scand J Caring Sci. 2005;19:140–7.CrossRefPubMed Muus I, Ringsberg KC. Stroke Specific Quality of Life Scale: Danish adaptation and a pilot study for testing psychometric properties. Scand J Caring Sci. 2005;19:140–7.CrossRefPubMed

go back to reference Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS. Quality of life declines after first ischemic stroke. The Northern Manhattan Study Neurology. 2010;75:328–34.PubMed Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS. Quality of life declines after first ischemic stroke. The Northern Manhattan Study Neurology. 2010;75:328–34.PubMed

go back to reference Alvarez-Sabín J, Santamarina E, Maisterra O, Jacas C, Molina C, Quintana M. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci. 2016;17:390.CrossRefPubMedPubMedCentral Alvarez-Sabín J, Santamarina E, Maisterra O, Jacas C, Molina C, Quintana M. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int J Mol Sci. 2016;17:390.CrossRefPubMedPubMedCentral

go back to reference Savitz SI, Baron JC, Fisher M. Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era. Stroke. 2019;50:1026–31.CrossRefPubMed Savitz SI, Baron JC, Fisher M. Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era. Stroke. 2019;50:1026–31.CrossRefPubMed

go back to reference Lyden P, Buchan A, Boltze J, Fisher M. Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI. Stroke. 2021;52:3063–71.CrossRefPubMedPubMedCentral Lyden P, Buchan A, Boltze J, Fisher M. Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI. Stroke. 2021;52:3063–71.CrossRefPubMedPubMedCentral

go back to reference Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, Conwit R, Liebeskind DS, Sung G, Kramer I, Moreau G, Goldweber R, Sanossian N. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372:528–36.CrossRefPubMedPubMedCentral Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, Conwit R, Liebeskind DS, Sung G, Kramer I, Moreau G, Goldweber R, Sanossian N. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372:528–36.CrossRefPubMedPubMedCentral

go back to reference Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hårdemark HG, Rodichok L. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke. 2008;39:1751–8.CrossRefPubMed Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hårdemark HG, Rodichok L. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke. 2008;39:1751–8.CrossRefPubMed

go back to reference Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol. 2014;13:453–60.CrossRefPubMed Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol. 2014;13:453–60.CrossRefPubMed

go back to reference Elkins J, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K, Lansberg MG, Tang W, Chang I, Muralidharan K, Gheuens S, Mehta L, Elkind MSV. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2017;16:217–26.CrossRefPubMed Elkins J, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K, Lansberg MG, Tang W, Chang I, Muralidharan K, Gheuens S, Mehta L, Elkind MSV. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2017;16:217–26.CrossRefPubMed

go back to reference Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke. 2016;47:2355–9.CrossRefPubMedPubMedCentral Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke. 2016;47:2355–9.CrossRefPubMedPubMedCentral

go back to reference Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, Poppe AY, Buck BH, Field TS, Dowlatshahi D, van Adel BA, Swartz RH, Shah RA, Sauvageau E, Zerna C, Ospel JM, Joshi M, Almekhlafi MA, Ryckborst KJ, Lowerison MW, Heard K, Garman D, Haussen D, Cutting SM, Coutts SB, Roy D, Rempel JL, Rohr AC, Iancu D, Sahlas DJ, Yu AYX, Devlin TG, Hanel RA, Puetz V, Silver FL, Campbell BCV, Chapot R, Teitelbaum J, Mandzia JL, Kleinig TJ, Turkel-Parrella D, Heck D, Kelly ME, Bharatha A, Bang OY, Jadhav A, Gupta R, Frei DF, Tarpley JW, McDougall CG, Holmin S, Rha JH, Puri AS, Camden MC, Thomalla G, Choe H, Phillips SJ, Schindler JL, Thornton J, Nagel S, Heo JH, Sohn SI, Psychogios MN, Budzik RF, Starkman S, Martin CO, Burns PA, Murphy S, Lopez GA, English J, Tymianski M. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395:878–87.CrossRefPubMed Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, Poppe AY, Buck BH, Field TS, Dowlatshahi D, van Adel BA, Swartz RH, Shah RA, Sauvageau E, Zerna C, Ospel JM, Joshi M, Almekhlafi MA, Ryckborst KJ, Lowerison MW, Heard K, Garman D, Haussen D, Cutting SM, Coutts SB, Roy D, Rempel JL, Rohr AC, Iancu D, Sahlas DJ, Yu AYX, Devlin TG, Hanel RA, Puetz V, Silver FL, Campbell BCV, Chapot R, Teitelbaum J, Mandzia JL, Kleinig TJ, Turkel-Parrella D, Heck D, Kelly ME, Bharatha A, Bang OY, Jadhav A, Gupta R, Frei DF, Tarpley JW, McDougall CG, Holmin S, Rha JH, Puri AS, Camden MC, Thomalla G, Choe H, Phillips SJ, Schindler JL, Thornton J, Nagel S, Heo JH, Sohn SI, Psychogios MN, Budzik RF, Starkman S, Martin CO, Burns PA, Murphy S, Lopez GA, English J, Tymianski M. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395:878–87.CrossRefPubMed

go back to reference Fan XX, Cao ZY, Liu MX, Liu WJ, Xu ZL, Tu PF, Wang ZZ, Cao L, Xiao W. Diterpene Ginkgolides Meglumine Injection inhibits apoptosis induced by optic nerve crush injury via modulating MAPKs signaling pathways in retinal ganglion cells. J Ethnopharmacol. 2021;279: 114371.CrossRefPubMed Fan XX, Cao ZY, Liu MX, Liu WJ, Xu ZL, Tu PF, Wang ZZ, Cao L, Xiao W. Diterpene Ginkgolides Meglumine Injection inhibits apoptosis induced by optic nerve crush injury via modulating MAPKs signaling pathways in retinal ganglion cells. J Ethnopharmacol. 2021;279: 114371.CrossRefPubMed

go back to reference Wang TJ, Wu ZY, Yang CH, Cao L, Wang ZZ, Cao ZY, Yu MY, Zhao MR, Zhang CF, Liu WJ, Zhao BJ, Shang XQ, Feng Y, Wang H, Deng LL, Xiao BG, Guo HY, Xiao W. Multiple Mechanistic Models Reveal the Neuroprotective Effects of Diterpene Ginkgolides against Astrocyte-Mediated Demyelination via the PAF-PAFR Pathway. Am J Chin Med. 2022;50:1565–97.CrossRefPubMed Wang TJ, Wu ZY, Yang CH, Cao L, Wang ZZ, Cao ZY, Yu MY, Zhao MR, Zhang CF, Liu WJ, Zhao BJ, Shang XQ, Feng Y, Wang H, Deng LL, Xiao BG, Guo HY, Xiao W. Multiple Mechanistic Models Reveal the Neuroprotective Effects of Diterpene Ginkgolides against Astrocyte-Mediated Demyelination via the PAF-PAFR Pathway. Am J Chin Med. 2022;50:1565–97.CrossRefPubMed

go back to reference Zhang W, Song JK, Yan R, Li L, Xiao ZY, Zhou WX, Wang ZZ, Xiao W, Du GH. Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling. Acta Pharmacol Sin. 2018;39:1259–72.CrossRefPubMedPubMedCentral Zhang W, Song JK, Yan R, Li L, Xiao ZY, Zhou WX, Wang ZZ, Xiao W, Du GH. Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling. Acta Pharmacol Sin. 2018;39:1259–72.CrossRefPubMedPubMedCentral

go back to reference Zhao S, Zheng H, Du Y, Zhang R, Chen P, Ren R, Wu S. The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2021;2021:4265219.CrossRefPubMedPubMedCentral Zhao S, Zheng H, Du Y, Zhang R, Chen P, Ren R, Wu S. The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2021;2021:4265219.CrossRefPubMedPubMedCentral

go back to reference Zhu PC, Tong Q, Zhuang Z, Wang ZH, Deng LH, Zheng GQ, Wang Y. Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis. Front Physiol. 2019;10:1292.CrossRefPubMedPubMedCentral Zhu PC, Tong Q, Zhuang Z, Wang ZH, Deng LH, Zheng GQ, Wang Y. Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis. Front Physiol. 2019;10:1292.CrossRefPubMedPubMedCentral

go back to reference Han JY, Meininger G, Luo JC, Huang QB. Editorial: Traditional Chinese Medicine: Organ Vascular Injury - Volume II. Front Physiol. 2021;12: 677858.CrossRefPubMedPubMedCentral Han JY, Meininger G, Luo JC, Huang QB. Editorial: Traditional Chinese Medicine: Organ Vascular Injury - Volume II. Front Physiol. 2021;12: 677858.CrossRefPubMedPubMedCentral

go back to reference Zhang Q, Wang A, Xu Q, Xia X, Tian X, Zhang Y, Li X, Yang X, Wang X, Peng J, Li Y, Liu L, Jin S, Meng X, Zhao X. Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Netw Open. 2023;6: e2328828.CrossRefPubMedPubMedCentral Zhang Q, Wang A, Xu Q, Xia X, Tian X, Zhang Y, Li X, Yang X, Wang X, Peng J, Li Y, Liu L, Jin S, Meng X, Zhao X. Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Netw Open. 2023;6: e2328828.CrossRefPubMedPubMedCentral

go back to reference Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–108.CrossRefPubMed Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–108.CrossRefPubMed

go back to reference Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203–20.CrossRefPubMed Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203–20.CrossRefPubMed

go back to reference Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17:597–604.CrossRefPubMed Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17:597–604.CrossRefPubMed

go back to reference Zhao H, Guo Q, Li B, Shi M. The Efficacy and Safety of Ginkgo Terpene Lactone Preparations in the Treatment of Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol. 2022;13: 821937.CrossRefPubMedPubMedCentral Zhao H, Guo Q, Li B, Shi M. The Efficacy and Safety of Ginkgo Terpene Lactone Preparations in the Treatment of Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol. 2022;13: 821937.CrossRefPubMedPubMedCentral

go back to reference Xubing Huang YL, Wenjing Cai. Effect of ginkgolide meglumine in NSE, hs-CRP and quality-of-life of patients with acute cerebral infarction. Linchuanghuicui. 2021;36:786–789. Xubing Huang YL, Wenjing Cai. Effect of ginkgolide meglumine in NSE, hs-CRP and quality-of-life of patients with acute cerebral infarction. Linchuanghuicui. 2021;36:786–789.

go back to reference xinjia Xu LL, Wufeng Li. Effect of ginkgo ketone ester dropping pills combined with Xueshuantong On blood lipid, nerve function and quality of life in patients with acute cerebral infarction. Zhonguoxiandaiyaowuyingyong. 2023;17:1–4. xinjia Xu LL, Wufeng Li. Effect of ginkgo ketone ester dropping pills combined with Xueshuantong On blood lipid, nerve function and quality of life in patients with acute cerebral infarction. Zhonguoxiandaiyaowuyingyong. 2023;17:1–4.

go back to reference Shao L, Dong C, Geng D, He Q, Shi Y. Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer’s disease. Metab Brain Dis. 2022;37:329–41.CrossRefPubMed Shao L, Dong C, Geng D, He Q, Shi Y. Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer’s disease. Metab Brain Dis. 2022;37:329–41.CrossRefPubMed

go back to reference Liu J, Ye T, Zhang Y, Zhang R, Kong Y, Zhang Y, Sun J. Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota. J Agric Food Chem. 2021;69:12230–40.CrossRefPubMed Liu J, Ye T, Zhang Y, Zhang R, Kong Y, Zhang Y, Sun J. Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota. J Agric Food Chem. 2021;69:12230–40.CrossRefPubMed

go back to reference Niu TT, Yin H, Xu BL, Yang TT, Li HQ, Sun Y, Liu GZ. Protective Effects of Ginkgolide on a Cellular Model of Alzheimer’s Disease via Suppression of the NF-κB Signaling Pathway. Appl Biochem Biotechnol. 2022;194:2448–64.CrossRefPubMedPubMedCentral Niu TT, Yin H, Xu BL, Yang TT, Li HQ, Sun Y, Liu GZ. Protective Effects of Ginkgolide on a Cellular Model of Alzheimer’s Disease via Suppression of the NF-κB Signaling Pathway. Appl Biochem Biotechnol. 2022;194:2448–64.CrossRefPubMedPubMedCentral

go back to reference Wang X, Zhao X, Johnston SC, Xian Y, Hu B, Wang C, Wang D, Liu L, Li H, Fang J, Meng X, Wang A, Wang Y, Wang Y. Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy. Neurology. 2015;85:573–9.CrossRefPubMedPubMedCentral Wang X, Zhao X, Johnston SC, Xian Y, Hu B, Wang C, Wang D, Liu L, Li H, Fang J, Meng X, Wang A, Wang Y, Wang Y. Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy. Neurology. 2015;85:573–9.CrossRefPubMedPubMedCentral

go back to reference Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, Peng Y, Han H, Wang J, Wang S, Yin C, Liu S, Wang P, Fang Q, Shi H, Yang J, Wen C, Li C, Jiang C, Sun J, Yue X, Lou M, Zhang M, Shu H, Sun D, Liang H, Li T, Guo F, Ke K, Yuan H, Wang G, Yang W, Shi H, Li T, Li Z, Xing P, Zhang P, Zhou Y, Wang H, Xu Y, Huang Q, Wu T, Zhao R, Li Q, Fang Y, Wang L, Lu J, Li Y, Fu J, Zhong X, Wang Y, Wang L, Goyal M, Dippel DWJ, Hong B, Deng B, Roos Y, Majoie C, Liu J. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. N Engl J Med. 2020;382:1981–93.CrossRefPubMed Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, Peng Y, Han H, Wang J, Wang S, Yin C, Liu S, Wang P, Fang Q, Shi H, Yang J, Wen C, Li C, Jiang C, Sun J, Yue X, Lou M, Zhang M, Shu H, Sun D, Liang H, Li T, Guo F, Ke K, Yuan H, Wang G, Yang W, Shi H, Li T, Li Z, Xing P, Zhang P, Zhou Y, Wang H, Xu Y, Huang Q, Wu T, Zhao R, Li Q, Fang Y, Wang L, Lu J, Li Y, Fu J, Zhong X, Wang Y, Wang L, Goyal M, Dippel DWJ, Hong B, Deng B, Roos Y, Majoie C, Liu J. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. N Engl J Med. 2020;382:1981–93.CrossRefPubMed

go back to reference Grool AM, van der Graaf Y, Witkamp TD, Vincken KL, Mali WP, Geerlings MI. Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study. J Aging Res. 2011;2011: 280630.CrossRefPubMedPubMedCentral Grool AM, van der Graaf Y, Witkamp TD, Vincken KL, Mali WP, Geerlings MI. Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study. J Aging Res. 2011;2011: 280630.CrossRefPubMedPubMedCentral